Vivos Adds Nutraceuticals to Address Oxidative Stress as Part of OSA Treatment

Summary: Vivos Therapeutics has partnered with Cellev8 Nutrition to enhance its obstructive sleep apnea (OSA) treatment offerings by introducing nutraceuticals that target oxidative stress. This collaboration combines Vivos’ FDA-cleared oral appliances with Cellev8’s antioxidant-rich formulations, aiming to address oxidative stress associated with OSA and provide a more holistic approach to patient care.

Key Takeaways:

1. Complementary Treatment Approach – Vivos’ FDA-cleared oral devices now pair with Cellev8’s nutraceuticals, designed to mitigate oxidative stress.
2. Focus on Systemic Recovery – The nutraceuticals aim to reduce oxidative damage, offering benefits beyond airway treatment by supporting overall health and recovery.
3. Holistic Care for OSA Patients – This partnership reflects Vivos’ commitment to addressing the broader impacts of OSA, integrating solutions for both airway function and systemic health.

Vivos Therapeutics and Cellev8 Nutrition announced a marketing venture aimed at providing comprehensive solutions for patients with obstructive sleep apnea (OSA) and associated oxidative stress. 

The collaboration combines Vivos Therapeutics’ US Food and Drug Administration-cleared oral medical devices for treating moderate to severe OSA in children and adults with Cellev8 Nutrition’s proprietary gummy form of nutraceuticals featuring the enzymatic antioxidant SOD2, designed to mitigate oxidative stress in the body.

Oxidative stress happens when the body has an imbalance between free radicals and antioxidants, leading to potential damage to cells and tissues, according to the National Institutes of Health’s National Cancer Institute. Various factors can contribute to this condition, including obesity, which is recognized as one of the most important reversible risk factors for OSA. 

“This joint venture enables us to offer a complementary product to help ameliorate the severe damage caused to virtually every major bodily system in OSA patients,” says Kirk Huntsman, CEO of Vivos Therapeutics, in a release. “Our Vivos treatment does a great job of restoring an airway, while Cellev8 Nutrition products can help the rest of the body rejuvenate and recover. We can easily see a large portion of our patients taking these products as an important part of their healing process.”

Prolonged oxidative stress is associated with aging and may contribute to chronic inflammation, cancer, and other health conditions, according to the National Cancer Institute.

Natural Approach to Health Management

This collaboration intends to provide a natural, scientifically backed solution through Cellev8 Nutrition’s lineup of nutraceutical products. The range includes inflammation and recovery, focus and memory, and the newly introduced SlimCell formulations. 

Cellev8 Nutrition’s proprietary blend of clinically proven ingredients has demonstrated efficacy in addressing multiple aspects of health. In a 12-week, double-blind placebo-controlled study, participants experienced an 8.8% decrease in stress levels, 9.4% reduction in physical fatigue, 13.9% improvement in cognitive functions, and 6.4% enhancement in general well-being.

Cellev8’s formulations have also shown:

• Oxidative stress reduction: A measurable decrease in markers of oxidative stress, a key factor in various chronic conditions including OSA.
• Long-term benefits: Even after improvement sustained by Vivos treatment, Cellev8’s nutraceuticals continue to aid in managing other chronic inflammatory causes, providing ongoing support for overall health.
• Anti-Inflammatory effects: Clinical studies have indicated a reduction in systemic inflammation, which is crucial for overall health and particularly relevant for OSA patients.
• Cognitive enhancement: The focus and memory gummies have demonstrated improvements in various cognitive functions, including attention, memory recall, and processing speed.
• Metabolic health: The SlimCell product line has shown promising results in weight management, with statistically significant reductions in body mass index observed in clinical trials.
• Body composition improvements: Participants in studies have experienced reductions in hip and waist circumferences, as well as a decrease in the appearance of cellulite, attributed to the anti-inflammatory properties of the formulations.

These benefits have been observed in controlled studies over periods of 30, 60, and 90 days of daily use, suggesting both short-term and sustained positive effects. 

FDA disclaimer: These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Photo caption: Cellev8’s inflammation & recovery

Photo credit: Cellev8

Further Reading for You:

Source